APPLICATOR, POVIDONE

The contract solicitation SPE2DS-26-T-069D seeks 4 packages of 50 individually sealed povidone-iodine impregnated applicators, identified by NSN 6510-01-519-5898, for delivery to Eglin AFB, Florida, with a required delivery date of May 14, 2026. The solicitation operates under simplified acquisition procedures and is subject to FAR Part 13, with packaging and marking requirements mandating compliance with MIL-STD-2073-1E as implemented through MPPWN00001 Rev 03/30/1988, and medical-specific labeling governed by Medical Marking Standard No. 1, which supersedes MIL-STD-129 except for radioactive materials. All units must be commercially packaged in sealed containers and shipped in suitable exterior containers to ensure safe delivery at the lowest applicable freight rate. The product is classified as a medical supply and is subject to the DLA Master List of Technical and Quality Requirements, with technical and quality specifications referenced by R and I numbers incorporated by full text. Hazardous material labeling must comply with OSHA’s Hazard Communication Standard, and offerors are required to submit pre-award hazard warning labels and Material Safety Data Sheets for review. The contract includes a suite of mandatory clauses covering cybersecurity compliance, employment eligibility verification, combating human trafficking, equal opportunity, sustainable products, and whistleblower rights, with numerous clauses modified by deviations issued in 2026. While the contract type remains unspecified, its nature as a simplified acquisition RFQ under FAR Part 13 implies a firm-fixed-price arrangement. Delivery is FOB destination, and invoicing must be submitted exclusively through Wide Area WorkFlow. The contracting officer is Seth Tootell of the Department of Defense’s Medical Supply Chain, and offerors must submit electronic proposals via the DIBBS portal by May 18, 2026, alongside current UEI and CAGE codes, accurate size status representations in SAM, and a current NIST SP 800-171 assessment. No contract value is listed in the pricing block, and award is anticipated to be based on a lowest price technically acceptable approach, though not formally stated.